SCHEMBL3663354

SCHEMBL3663354

COc1cccc(C(=O)NC2CCC(N(C)C)CC2)c1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.61
TSHR P16473 1/20 0.61
MCHR1 Q99705 3/20 0.61
NPC1 O15118 2/20 0.60
GRM5 P41594 1/20 0.59
SMN1; SMN2 Q16637 4/20 0.56
LMNA P02545 4/20 0.56
RAB9A P51151 2/20 0.56
GAA P10253 1/20 0.56
PKM P14618 1/20 0.54
HPGD P15428 1/20 0.54
MAPK1 P28482 2/20 0.53
MAPT P10636 1/20 0.53
HTT P42858 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
SMYD3 Q9H7B4 1/20 0.52
CCR3 P51677 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2468483 0.91 NPC1 (0.71) ALDH1A1TSHRMCHR1NPC1GRM5
SCHEMBL1667825 0.85 RAB9A (0.73) ALDH1A1TSHRNPC1GRM5SMN1; SMN2
SCHEMBL6455626 0.84 SMYD3 (0.69) ALDH1A1TSHRMCHR1NPC1GRM5
SCHEMBL6455623 0.84 SMYD3 (0.69) ALDH1A1TSHRMCHR1NPC1GRM5
SCHEMBL11241115 0.84 RAB9A (0.75) ALDH1A1TSHRNPC1GRM5SMN1; SMN2
SCHEMBL30098987 0.82 ALDH1A1 (0.63) ALDH1A1TSHRMCHR1NPC1GRM5
SCHEMBL1711687 0.82 ALDH1A1 (0.63) ALDH1A1TSHRMCHR1NPC1GRM5
SCHEMBL29530916 0.82 ALDH1A1 (0.63) ALDH1A1TSHRMCHR1NPC1GRM5
SCHEMBL30938355 0.81 MCHR1 (0.51) ALDH1A1TSHRMCHR1NPC1GRM5
SCHEMBL4516387 0.81 ALDH1A1 (0.72) ALDH1A1TSHRMCHR1NPC1GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212326-A1 2-ANILINOPURIN-8-ONES AS INHIBITORS OF TTK/MPS1 FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AstraZeneca AB (SE) 2010-08-04 EP disclosed
WO-2009024824-A1 2-ANILINOPURIN-8-ONES AS INHIBITORS OF TTK/MPS1 FOR THE TREATMENT OF PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2009-02-26 WO disclosed